Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464599011 | Alosetron (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2470959011 | Alosetron | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3486693013 | Product containing alosetron (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3495030018 | Product containing alosetron | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3667081012 | Alosetron product | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3713070012 | Alosetron-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing alosetron (medicinal product) | Is a | Product containing 5-hydroxytryptamine-3-receptor antagonist (product) | true | Inferred relationship | Some | ||
| Product containing alosetron (medicinal product) | Has active ingredient | Alosetron | true | Inferred relationship | Some | 1 | |
| Product containing alosetron (medicinal product) | Is a | Inflammatory bowel disease drug | false | Inferred relationship | Some | ||
| Product containing alosetron (medicinal product) | Is a | Medicinal product categorized by structure | false | Inferred relationship | Some | ||
| Product containing alosetron (medicinal product) | Is a | Product containing imidazole (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely alosetron hydrochloride 1 milligram/1 each conventional release oral tablet | Is a | False | Product containing alosetron (medicinal product) | Inferred relationship | Some | |
| Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet | Is a | False | Product containing alosetron (medicinal product) | Inferred relationship | Some | |
| Alosetron-containing product in oral dose form | Is a | True | Product containing alosetron (medicinal product) | Inferred relationship | Some | |
| Alosetron only product | Is a | True | Product containing alosetron (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR